Di Lu

机构：Shenyang Medical College, Shandong University, Guangdong Academy of Medical Sciences, China Medical University, Guangzhou Medical University · ORCID：0000-0002-8635-6512

发表论文 100 篇 · 总被引 1644 次 · h-index 18

代表论文

• Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4) (2023 · JACC Asia · 被引 33)
• Functional design and biomechanical evaluation of 3D printing PEEK flexible implant for chest wall reconstruction (2022 · Computer Methods and Programs in Biomedicine · 被引 27)
• LncRNA miR205HG hinders HNRNPA0 translation: anti‐oncogenic effects in esophageal carcinoma (2021 · Molecular Oncology · 被引 20)
• Integrative pan cancer analysis reveals the importance of CFTR in lung adenocarcinoma prognosis (2022 · Genomics · 被引 15)
• Machine vision-assisted identification of the lung adenocarcinoma category and high-risk tumor area based on CT images (2022 · Patterns · 被引 13)
• A deep learning based CT image analytics protocol to identify lung adenocarcinoma category and high-risk tumor area (2022 · STAR Protocols · 被引 11)